Skip to main content

Peer Review reports

From: Treatment of non-high-risk acute promyelocytic leukemia with realgar-indigo naturalis formula (RIF) and all-trans retinoid acid (ATRA): study protocol for a randomized controlled trial

Original Submission
1 Feb 2019 Submitted Original manuscript
24 May 2019 Reviewed Reviewer Report - Ruth Knight
20 Jun 2019 Reviewed Reviewer Report - Susan J Dutton
17 Jul 2019 Author responded Author comments - Xinxin Zhang
Resubmission - Version 2
17 Jul 2019 Submitted Manuscript version 2
26 Jul 2019 Reviewed Reviewer Report - Ruth Knight
1 Sep 2019 Author responded Author comments - Xinxin Zhang
Resubmission - Version 3
1 Sep 2019 Submitted Manuscript version 3
3 Oct 2019 Reviewed Reviewer Report - Ruth Knight
16 Nov 2019 Author responded Author comments - Xinxin Zhang
Resubmission - Version 4
16 Nov 2019 Submitted Manuscript version 4
Publishing
10 Dec 2019 Editorially accepted
2 Jan 2020 Article published 10.1186/s13063-019-3983-2

You can find further information about peer review here.

Back to article page